1Capeans C, Lorenzo J, Santos L, Suarez A, Copena MJ,Blanco MJ, et al. Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy[J]. Graefe Arch Clin Exp Ophthalmol 1998; 236 (7) : 481.-485.
2Wang FH, Wang ZL, Sun XD, Wang F, Xu X, Zhang X. The safety of dtspase and plasmin in inducing posterior vitreous detachment [ J ]. Invest Ophthalmol Vis Sci 2004 ; 45(9) : 3286-3290.
3Unal M, Peyman GA. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment[J]. Retina 2000;20(1 ) :69-75.
4Gandorfer A, Putz E, Welge-Lussen U. Ultrastructure of the vttreorettnal interface following plasmin assisted vitrectomy [ J ]. Br J Ophthalmol 2001 ; 85 ( 1 ) : 6-10.
5Hikichi T, Kado M, Yoshida A. Intravttreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit[J]. Retina 2000;20(2) : 195-198.
6Fong AC,Schatz H.Central retinal vein occlusion in young adults[J].Surv Ophthalmol 1993;37(6):393-417.
7Chen JC, Klein ML, Watzke RC, Handelman IL, Robertson JE. Natural course of perfused central retinal vein occlusion[J].Can J Ophthalmol 1995;30(1):21-24.
8Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. Prognostic factors for retinal vein occlusion: prospective study of 175 cases[J].Ophthalmology 1996;103(4):551-560.
9The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion[J].Arch Ophthalmol 1996;114:545-554.
10The Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion[J].Am J Ophthalmol 1993;116:286-292.
